Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Tonix Pharmaceuticals Holding Corp (TNXP)

  • Event
  • Aug. 05, 2022, 21:02 UTC
  • 34
  • 1 comments

(99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Executive Changes

Comment Full text

Avadel Pharmaceuticals (AVDL)

  • Event
  • Aug. 05, 2022, 20:58 UTC
  • 35
  • 1 comments

(99% Neutral) AVADEL PHARMACEUTICALS PLC (AVDL) Announces Regulatory Update

Comment Full text

Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA)) (BTX)

  • Event
  • Aug. 05, 2022, 20:32 UTC
  • 36
  • 1 comments

(99% Neutral) Brooklyn ImmunoTherapeutics, Inc. (BTX) Announces Executive Changes

Comment Full text

Arvinas Inc (ARVN)

  • Event
  • Aug. 05, 2022, 20:12 UTC
  • 35
  • 1 comments

(90% Positive) Arvinas, Inc. (ARVN) Provides Update on availability for bavdegalutamide

Comment Full text

Arcutis Biotherapeutics (ARQT)

  • Event
  • Aug. 05, 2022, 20:02 UTC
  • 34
  • 1 comments

(99% Neutral) ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Announces Business Combination

Comment Full text

Legend Biotech (LEGN)

  • Event
  • Aug. 05, 2022, 12:30 UTC
  • 33
  • 1 comments

(10% Negative) Legend Biotech (LEGN) Announces Clinical Development Update (Form 6-K)

Comment Full text

Twist Bioscience (TWST)

  • Event
  • Aug. 05, 2022, 11:35 UTC
  • 33
  • 1 comments

(10% Negative) Twist Bioscience Corporation (TWST) Reports Q3 2022 Financial Results

Comment Full text

Forma Therapeutics Holdings Inc (the company became a subdivision of the company Novo Nordisk (NYSE: NVO)) (FMTX)

  • Event
  • Aug. 05, 2022, 11:30 UTC
  • 34
  • 1 comments

(30% Negative) FORMA THERAPEUTICS HOLDINGS, INC. (FMTX) Reports Q3 2022 Financial Results

Comment Full text

Oncorus Inc (was bankruptcy on 02/0/2023) (ONCR)

  • Event
  • Aug. 05, 2022, 11:10 UTC
  • 36
  • 1 comments

(99% Neutral) ONCORUS, INC. (ONCR) Announces Regulatory Update

Comment Full text

Immunovant Inc (IMVT)

  • Event
  • Aug. 05, 2022, 11:07 UTC
  • 33
  • 1 comments

(30% Negative) IMMUNOVANT, INC. (IMVT) Reports Q3 2022 Financial Results

Comment Full text
  • Previous
  • 524
  • 525
  • 526
  • 527
  • 528
  • Next

Search

News categories

  • Technical Exchange News(12475)
  • Event(6229)
  • SEC News(281310)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(161346)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin